Urology Medical Revenue Recovery Firm

A urology medical revenue recovery firm examines the points where appropriate reimbursement may be delayed, reduced, or missed. This can include coding issues, claim denials, prior authorization, unbilled encounters, missed charges, uncaptured supplies, contractual underpayment, unworked appeals, and patient balances. For urology practices, the review can also connect procedure economics and operational capacity to the revenue cycle so financial decisions are based on the practice’s actual activity.

GrowUrology provides urology-focused explainers, calculators, assessments, and optional practice analysis. A practice can examine its own claims, denial, payment, capacity, and procedure information to identify likely leakage points. Areas may include documentation, modifiers, medical necessity, authorization, charge capture, payment variance, appeals, and follow-up. The platform emphasizes visible methodology and avoids presenting unsupported rates, costs, or benchmarks as established facts.

GrowUrology is a business-resource site published and funded by Persistex, a medical billing, coding, and revenue-cycle-management firm. The catalog describes optional support for practices that want analysis performed for them, followed by ongoing billing, coding, and RCM services. GrowUrology also offers self-service resources for practices that prefer to examine their own decisions and data directly.

Reviews can address denial root causes, modifier 25 and modifier 59 concerns, laterality, medical necessity documentation, prior authorization, unbilled encounters, missed charges, uncaptured supplies, contractual underpayment, appeals, and abandoned patient balances. The appropriate review depends on the practice’s services, data, payer mix, and workflows. GrowUrology’s approach is to categorize issues by cause and financial significance rather than treat every item as an identical worklist.

Yes. The service catalog describes a process for separating recoverable soft denials from hard denials, identifying invisible contractual underpayment, and using authoritative sources such as CMS fee schedules, NCCI edits, LCDs, and AUA coding guidance. A useful review should compare the claim, documentation, coding, payer response, and applicable contract or policy information before determining whether an appeal, correction, or contractual review is appropriate.

Yes. Prior authorization is treated as a revenue-protection process rather than an isolated administrative task. The described approach includes assigning ownership, tracking the authorization clock, creating an escalation path, and confirming approval before scheduled services when required. The goal is to reduce avoidable delays, prevent authorization-related denials, and protect the financial performance of procedures that require payer approval.

Yes. GrowUrology includes procedure profitability and equipment return-on-investment tools designed to use the practice’s own inputs. Practice economics analysis can examine contribution margin after direct costs and consider how site of service changes the economics of the same CPT code. This helps owners evaluate procedure lines, equipment, staffing, and expansion opportunities using practice-specific information rather than vendor-driven assumptions.

Yes. GrowUrology is positioned for independent urology practices, independent urologists, practice owners, and practice administrators. Its resources address the business side of urology, including reimbursement, coding, revenue cycle management, procedure economics, staffing, capacity, payer decisions, capital planning, and service-line evaluation. The platform is designed to help clinical leaders understand financial implications without replacing appropriate clinical, legal, compliance, or accounting advice.